Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
about
Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened CochleaEnhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig.Intracochlear drug delivery in combination with cochlear implants : Current aspects[Intracochlear drug delivery in combination with cochlear implants : Current aspects].Viral-mediated Ntf3 overexpression disrupts innervation and hearing in nondeafened guinea pig cochleaeGene therapy in the inner ear using adenovirus vectors.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.Postnatal expression of neurotrophic factors accessible to spiral ganglion neurons in the auditory system of adult hearing and deafened rats.TrkB-mediated protection against circadian sensitivity to noise trauma in the murine cochlea.The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.A review of gene delivery and stem cell based therapies for regenerating inner ear hair cellsEffects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.Cochlear implants: a remarkable past and a brilliant future.Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.BDNF gene therapy induces auditory nerve survival and fiber sprouting in deaf Pou4f3 mutant mice.Current status and prospects of gene therapy for the inner earBrain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.Regeneration of Hair Cells: Making Sense of All the Noise.Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimizationBiotechnology in the treatment of sensorineural hearing loss: foundations and future of hair cell regeneration.Localized cell and drug delivery for auditory prostheses.Inner ear drug delivery for auditory applications.Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons.Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro.Efficient transduction of spiral ganglion cells using adenovirus type 5 vector in the rat.Gene therapy for the inner ear: challenges and promises.Sarcopenia and Hearing Loss in Older Koreans: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010Cochlear implants: current status and future potential.Neurotrophins and cochlear implants: a solution to sensorineural deafness?The Trk A, B, C's of neurotrophins in the cochlea.Developments in delivery of medications for inner ear disease.Carriers in cell-based therapies for neurological disorders.Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures.In vivo evaluation of a neural stem cell-seeded prosthesis.Gene therapy, early promises, subsequent problems, and recent breakthroughs.Early interfaced neural activity from chronic amputated nerves.Protective effects of brain-derived neurotrophic factor on the noise-damaged cochlear spiral ganglion.An animal model of cochlear implantation with an intracochlear fluid delivery system.A device for patterned electrical stimulation of cultivated cells: preliminary tests with rat auditory neurons.
P2860
Q28553035-96E0BB2B-109B-4AFA-8268-928242AA86B2Q28740987-9F04CFEB-C253-4968-AD45-4C5F364F0803Q30313632-6EFE17C2-0E2A-4D91-9901-F7D74E31DA81Q30313814-7267F8F9-2A6C-4453-814B-9871AD953B05Q30376584-5B3BF009-414A-4A11-8AF1-8C89E52E4154Q30409346-DEE1C334-2D12-4B07-9F0F-AEA1D8AB164AQ30411312-25350264-68A6-4074-B269-3B6656C6360EQ30416157-BD34004E-6452-425E-AAD5-84D638B6074BQ30416567-9C1A7C22-EEC9-487B-8D31-86DFD26EC6BBQ30435375-B9216B55-30C4-4066-9046-6D5D2E2C771BQ30436837-5E2CC199-A2A2-436D-8477-29E1418D8BD8Q30440839-C57E04B0-A296-4D86-933B-6BE85B9A63C1Q30443252-4259575C-AB4F-47B8-AF05-AABBC6460328Q30452445-4BD062A0-7173-4E6D-9520-98261279C892Q30458466-EDC63755-6AF0-4673-888A-D32081FE7807Q30460999-06CACA0A-3DC3-4B59-8683-1554ECD61F4CQ30461494-F7AAF8FE-54C5-43C9-AC64-8154752BFEB1Q30467124-30DE04C3-9FFA-4D37-BA9D-AF8656096F78Q30467210-B9FB8EFA-735F-4969-853F-D0242439E00BQ30467283-0AE9F829-1FB8-4FC8-B012-410A80E4687DQ30472053-8E0594B2-66D4-4F0B-8DAB-161B61967FA7Q30475885-721EE30F-CE90-466C-A03A-4777549D4B4AQ30484636-5621DEC7-885D-46C0-BCC0-6A8CF9E2DECFQ30485604-E3CB332A-DDD6-47D3-BDD2-E8399D57E507Q30487519-D6780A81-13B3-4A4E-A361-618EE4681DB3Q33537349-9E9864D0-8C12-4255-A790-5E5AE4BA789CQ35095260-87A0270C-791C-4D33-A573-EE795DC2A8D5Q35957935-14D07FD9-B539-4B0C-AC42-B6773E77798EQ37871997-41DE8A82-01D8-4C2A-82CD-1DCE6D7BABF5Q38034287-C0CA8F01-9039-41BC-B557-E12FF0E624E9Q38050349-39F7D2F9-F1FF-4C83-AEF8-43EBF35C1867Q38096427-87859639-066B-4B3E-9F58-985D4F2EEDCCQ38220613-B48DAB77-C624-4631-8E8C-A76CCFAF67CEQ38641765-85EA1DC9-BF42-464E-A4ED-657CB807A8D1Q39872733-D6CCDAB9-B6C4-4030-9068-294981BEB1BEQ41807910-BF6C83E7-EF05-42F5-A1AE-0FB3F03CE8F8Q43117158-464B67DF-5556-4B48-96B8-ACA4124BEC57Q46225510-87920773-F99C-42BE-ACDD-39EE51033C73Q48422641-D43E4F03-97C8-4E30-AA58-DB7D675E8C2CQ48513501-5154068E-423A-4815-935E-BFEEE1091D1E
P2860
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@en
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@nl
type
label
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@en
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@nl
prefLabel
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@en
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@nl
P2093
P2860
P1433
P1476
Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
@en
P2093
Darius Rejali
Donald L Swiderski
Karen A Abrashkin
Nousheen Humayun
Valerie A Lee
Yehoash Raphael
P2860
P304
P356
10.1016/J.HEARES.2007.02.010
P577
2007-03-07T00:00:00Z